Imeri L, Mancia M, Bianchi S, Opp M R
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston 77555-0431, USA.
Neuroscience. 2000;95(2):445-52. doi: 10.1016/s0306-4522(99)00435-2.
The precise role of serotonin (5-hydroxytryptamine) in the regulation of sleep is not fully understood. To further clarify this role for 5-hydroxytryptamine, the 5-hydroxytryptamine precursors L-tryptophan (40 and 80 mg/kg) and L-5-hydroxytryptophan (25-, 50-, 75-, 100 mg/kg) were injected intraperitoneally into freely behaving rats 15 min prior to dark onset, and subsequent effects on sleep-wake activity and cortical brain temperature were determined. L-5-hydroxytryptophan, but not L-tryptophan, induced dose-dependent changes in sleep-wake activity. During the 12-h dark period, non-rapid eye movement sleep was inhibited in post-injection hours 1-2 by the two lowest L-5-hydroxytryptophan doses tested, while the two highest doses induced a delayed increase in non-rapid eye movement sleep in post-injection hours 3-12. These highest doses inhibited non-rapid eye movement sleep during the subsequent 12-h light period. The finding that L-5-hydroxytryptophan, but not L-tryptophan, induced a dose-dependent and long-lasting decrease in cortical brain temperature regardless of whether or not non-rapid eye movement sleep was suppressed or enhanced contributes to a growing list of conditions showing that sleep-wake activity and thermoregulation, although normally tightly coupled, may be dissociated. The initial non-rapid eye movement sleep inhibition observed following low doses of L-5-hydroxytryptophan may be attributable to increased serotonergic activity since 5-hydroxytryptamine may promote wakefulness per se, whereas the delayed non-rapid eye movement sleep enhancement after higher doses may be due to the induction by 5-hydroxytryptamine of sleep-inducing factor(s), as previously hypothesized. The period of non-rapid eye movement sleep inhibition beginning 12 h after administration of L-5-hydroxytryptophan doses that increase non-rapid eye movement sleep is characteristic of physiological manipulations in which non-rapid eye movement sleep is enhanced. The results of the present study suggest that the complex effects of 5-HT on sleep depend on the degree and time course of activation of the serotonergic system such that 5-HT may directly inhibit sleep, yet induce a cascade of physiological processes that enhance subsequent sleep.
血清素(5-羟色胺)在睡眠调节中的精确作用尚未完全明确。为进一步阐明5-羟色胺的这一作用,在黑暗开始前15分钟,将5-羟色胺前体L-色氨酸(40和80毫克/千克)以及L-5-羟色氨酸(25、50、75、100毫克/千克)腹腔注射到自由活动的大鼠体内,随后测定对睡眠-觉醒活动和皮层脑温的影响。L-5-羟色氨酸而非L-色氨酸诱导了睡眠-觉醒活动的剂量依赖性变化。在12小时的黑暗期内,测试的两个最低剂量的L-5-羟色氨酸在注射后1-2小时抑制了非快速眼动睡眠,而两个最高剂量在注射后3-12小时诱导非快速眼动睡眠延迟增加。这些最高剂量在随后的12小时光照期抑制了非快速眼动睡眠。无论非快速眼动睡眠是被抑制还是增强,L-5-羟色氨酸而非L-色氨酸都能诱导皮层脑温出现剂量依赖性且持久的下降,这一发现增加了越来越多表明睡眠-觉醒活动和体温调节虽通常紧密相关但可能分离的情况。低剂量L-5-羟色氨酸后最初观察到的非快速眼动睡眠抑制可能归因于血清素能活性增加,因为5-羟色胺本身可能促进觉醒,而高剂量后延迟的非快速眼动睡眠增强可能如先前假设的那样是由于5-羟色胺诱导了睡眠诱导因子。在给予增加非快速眼动睡眠的L-5-羟色氨酸剂量12小时后开始的非快速眼动睡眠抑制期是增强非快速眼动睡眠的生理操作的特征。本研究结果表明,5-羟色胺对睡眠的复杂影响取决于血清素能系统激活的程度和时间进程,使得5-羟色胺可能直接抑制睡眠,但会引发一系列增强后续睡眠的生理过程。